$Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma$

Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma

Abstract TNB‐383B is a fully human BCMA‐targeting T‐cell engaging bispecific monoclonal antibody (T‐BsAb). We assessed ex vivo efficacy of this drug to mediate killing of bone marrow mononuclear cells (BMMCs) freshly isolated from 10 patients with relapsed multiple myeloma (MM). BMMC were treated ex...

Full description

Bibliographic Details
Main Authors:	David M. Foureau, Manisha Bhutani, Myra Robinson, Fei Guo, Duy Pham, Ben Buelow, Nury Steuerwald, Katherine Rigby, Elise Tjaden, Marina Leonidas, Barry A. Paul, Shebli Atrash, Ami Ndiaye, James T. Symanowski, Peter M. Voorhees, Saad Z. Usmani
Format:	Article
Language:	English
Published:	Wiley 2020-07-01
Series:	eJHaem
Subjects:	antibody therapy immunophenotyping myeloma
Online Access:	https://doi.org/10.1002/jha2.69

Similar Items

Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
by: David Foureau, et al.
Published: (2021-10-01)

Flow cytometry principles for clinical laboratory practice : quality assurance for quantitative immunophenotyping /
by: 409867 Owens, Marilyn A., et al.
Published: (1995)

P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
by: Katja Weisel, et al.
Published: (2023-08-01)

Immunophenotypic Characterization of Peripheral Blood T-Lymphocytes and Their Subpopulations in Tuberculosis Patientsbefore and after Treatments
by: Zohreh Pessaran, et al.
Published: (2005-03-01)

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
by: Manisha Bhutani, et al.
Published: (2025-02-01)

Improving outcomes with anti-BCMA bispecific antibodies with attention to infection
by: Andrew J. Yee
Published: (2024-07-01)

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
by: Fumou Sun, et al.
Published: (2024-01-01)

Development of BCMA-Targeted Bispecific Natural Killer Cell Engagers for Multiple Myeloma Treatment
by: Minchuan Zhang, et al.
Published: (2024-11-01)

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy
by: Wei Zhang, et al.
Published: (2024-08-01)

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1
by: Irene Cattaneo, et al.
Published: (2024-02-01)

Phenotypic Profiling of Immune Cells and Their Mediators in Chronic Obstructive Pulmonary Disease
by: Meghashree Sampath, et al.
Published: (2023-08-01)

High‐grade B‐cell lymphoma with MYC and BCL2 rearrangements with abundant multinucleated giant tumor cells
by: Man Zhang, et al.
Published: (2023-05-01)

An Unusual Case of Primary Plasma Cell Leukaemia Mimicking Acute Leukaemia: A Case Report and Review of Literature
by: Abha Singla, et al.
Published: (2017-12-01)

Myeloid Sarcoma: Evaluation of Histopathology, Immunoprofile and Cytogenetics
by: Sanjiban Patra, et al.
Published: (2021-03-01)

NECESSITY OF AGE-RELATED STANDARDS FOR IMMUNE PHENOTYPING OF BLOOD CELLS FOR MONITORING OF HEALTH IN CHILDREN BORN BY HIV-INFECTED WOMEN
by: B. A. Bakhmetyev, et al.
Published: (2012-05-01)

Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity
by: Aleksandra Bożyk, et al.
Published: (2022-06-01)

Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errors
by: Michelle Huang, et al.
Published: (2022-11-01)

Utility of flow cytometry in diagnosis of acute leukemias: A Study at RIMS, Ranchi, India
by: Sunil K Mahto, et al.
Published: (2022-01-01)

Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry"
by: Gujral Sumeet, et al.
Published: (2008-04-01)

Flowcytometry in Chronic B-Cell Lymphoproliferative Disorders: A Retrospective Study from a Tertiary Oncology Centre, Trivandrum, India
by: CM Simi, et al.
Published: (2021-09-01)

The Study of Gastrointestinal Lymphoma Immunophenotypes in Admitted Patients of Hamadan Hospitals and Relationship between 2 Years Survival with Patient Age, Immunophenotype and Site of the Tumor
by: Arash Dehghan, et al.
Published: (2013-03-01)

Pediatric multifocal histiocytic sarcoma- a fatal diagnosis not to miss!
by: Darilin Shangpliang, et al.
Published: (2021-07-01)

Clinicopathological Profile and Outcomes of Follicular Dendritic Cell Sarcoma of the Head and Neck Region - A Study of 10 Cases with Literature Review
by: Usha Amirtham, et al.
Published: (2016-08-01)

Idiopathic CD4+ T-cell Lymphocytopenia: Report of a Case 11 Years after Diagnosis
by: Noel Lorenzo Villalba, et al.
Published: (2020-03-01)

A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
by: Heng Mei, et al.
Published: (2021-10-01)

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
by: Eugenia Zah, et al.
Published: (2020-05-01)

P977: BISPECIFIC CS1-BCMA CAR-T CELLS ARE CLINICALLY ACTIVE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
by: C. Li, et al.
Published: (2022-06-01)

The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
by: Lindsay Hammons, et al.
Published: (2023-08-01)

APPLICATION OF SIX-COLOR FLOW CYTOMETRIC ANALYSIS FOR IMMUNE PROFILE MONITORING
by: I. V. Kudryavtsev, et al.
Published: (2015-03-01)

EXPERIENCE IN LOCAL IMMUNOCORRECTION IN TREATMENT OF CHRONIC WOUNDS
by: I. A. Novikova, et al.
Published: (2014-07-01)

CAR-T cells microscopic and phenotypic identification in the peripheral blood
by: LESESVE
Published: (2022-02-01)

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry
by: O. Yu. Davydova, et al.
Published: (2019-01-01)

Mycosis fungoides: improving the diagnostics of early and late stages by quantifying the results of immunohistochemical studies of skin biopsy
by: I. A. Kuklin, et al.
Published: (2021-06-01)

CD4+ chronic lymphocytic leukemia in an 86‐year‐old male veteran: A case report
by: Sara Abdelrahim, et al.
Published: (2024-08-01)

Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS
by: Tobias Zrzavy, et al.
Published: (2024-04-01)

Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology
by: Na Zhang, et al.
Published: (2024-04-01)

Clinical and Clinical Pathological Presentation of 310 Dogs Affected by Lymphoma with Aberrant Antigen Expression Identified via Flow Cytometry
by: Elena Celant, et al.
Published: (2022-04-01)

Flow Cytometry: A Blessing and a Curse
by: Hannah Drescher, et al.
Published: (2021-11-01)

Synovial Sarcoma of the Extremities: A Literature Review
by: Cosmin Ioan Faur, et al.
Published: (2021-08-01)

Multiparameter Flowcytometry for Diagnosis and Subtyping of Mature Lymphocytic Neoplasms in Peripheral Blood and Bone Marrow: A Prospective Observational Study
by: Shailendra Jambhulkar, et al.
Published: (2022-07-01)